comprehensive -WSS

comprehensive

author：comprehensive 2025-09-27 22:46:51 - browse：261

Illustration of a brain maze. -- biotech coverage from STAT — Adobe

The brain remains both the body’s most important organ and its least understood. But a draft atlas of the human brain published on Thursday gives scientists important insights into how it works and may pave the way for big advances in disease treatment and diagnosis.

This brain map, pieced together by hundreds of researchers from San Diego to Seattle to Stockholm, is essentially a cellular “parts list” of the human brain and a guide to how those pieces are arranged and work together. Scientists say that what they’ve already learned — including a stunning diversity of cell types in the brain — and what they’ll discover in the years to come will improve our understanding of deadly neurological diseases.

At the heart of this effort are some of biology’s most fundamental questions. How do mutations contribute to disease? What makes people different from one another? And what makes humans different from other primates?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Doctors' information doesn't help them choose wisely when sick

explore

WSS

Medicare Advantage proposed rates disappoint insurers

Liz Cheney makes 1st public comment since Trump's election interference indictments

Biogen Alzheimer’s drug launch off to slow start

What we’ve learned from the Aduhelm mess

Medicare Advantage proposed rates disappoint insurers

PhRMA lawsuit over Medicare drug price negotiation tossed

leisure time

comprehensive

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

The Readout: Gilead, Bernie Sanders, and other pharma news

Novavax promises a turnaround & Lilly roils the obesity market

Listen: Racing for gene therapy & a pioneering approval

Novavax promises a turnaround & Lilly roils the obesity market

A disappointing year of Humira biosimilars

Drug repurposing or repositioning? The language matters

FDA approves first treatment for ultra

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout LOUD podcast: How biotech is using artificial intelligence

entertainment

FDA approves first treatment for ultra

Listen: Racing for gene therapy & a pioneering approval

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Biogen Alzheimer’s drug launch off to slow start

Senators start work on Medicare physician payment reform

Lung cancer is America's deadliest cancer. Yet so few get screened

knowledge

explore

knowledge

focus